stocksBIOGEN
BIOGEN

Biogen Pharmachem Industries Ltd.

Industry Group: Finance
0.28+0.0 (+3.70%)
25 Aug, 12:00 AM

Annual Reports and Financial Documents

Biogen Pharmachem Industries Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2013201420152016201720182019202020212022202320242025
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Biogen Pharmachem Industries Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Reg. 32 (1), (3) - Statement of Deviation & Variation5 Aug 2026
    Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
    PFA
  2. Outcome of Board Meeting5 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th August 2026.
    Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....
  3. Board Meeting21 Jul 2026
    Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
    Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
  4. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    PFA
  5. Closure of Trading Window12 Jun 2026
    Closure of Trading Window
    PFA
  6. Reg.24(A)-Annual Secretarial Compliance23 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    PFA
  7. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120 May 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd
  8. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120 May 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd
  9. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120 May 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parichay Infrastructure Ltd
  10. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 May 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Interface Financial Services Ltd
  11. Allotment of Equity Shares18 May 2026
    Announcement under Regulation 30 (LODR)-Allotment
    PFA
  12. Reg. 32 (1), (3) - Statement of Deviation & Variation14 May 2026
    Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
    PFA
  13. Outcome of Board Meeting14 May 2026
    Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2026 And Outcome Of The Board Meeting Held On Thursday 14Th May 2026.
    This is to inform you that Outcome of the Board Meeting of the Company held on today i.e. Thursday 14th May 2026 in accordance with SEBl (Listing Obligations and Disclosures Requirements) ....
  14. Board Meeting4 May 2026
    Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
    Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
  15. Amendments to Memorandum & Articles of Association27 Apr 2026
    Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
    PFA
  16. Postal Ballot27 Apr 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Results of Postal Ballot Notice Dated 23rd March 2026
  17. Postal Ballot27 Apr 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    PFA
  18. Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A22 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  19. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    PFA
  20. Record Date1 Apr 2026
    Regulation 42 As Per SEBI LODR Intimation Of Record Date For Issuance Of Bonus Shares In The Proportion Of 1:6 I.E. 1 (One) New Equity Shares Of Rs.1/- Each For Every 6 (Six) Existing Equity Shares Of Rs.1/- Each Fully Paid Up And Held By The Members/ Beneficial Owner
    PFA

Frequently Asked Questions

Where can I download the annual report of Biogen Pharmachem Industries Ltd.?
Annual reports of Biogen Pharmachem Industries Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Biogen Pharmachem Industries Ltd.?
Quarterly earnings results and presentations of Biogen Pharmachem Industries Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Biogen Pharmachem Industries Ltd. publish earnings call transcripts?
Earnings call transcripts of Biogen Pharmachem Industries Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Biogen Pharmachem Industries Ltd.?
Investor presentations and annual day presentations of Biogen Pharmachem Industries Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Biogen Pharmachem Industries Ltd.?
Corporate announcements and regulatory filings of Biogen Pharmachem Industries Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Biogen Pharmachem Industries Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Biogen Pharmachem Industries Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Biogen Pharmachem Industries Ltd.?
The ISIN (International Securities Identification Number) of Biogen Pharmachem Industries Ltd. is INE703D01023. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Biogen Pharmachem Industries Ltd. listed?
Biogen Pharmachem Industries Ltd. is listed on NSE and BSE. The NSE symbol is BIOGEN and the BSE code is -.
Where can I find the shareholding pattern of Biogen Pharmachem Industries Ltd.?
The quarterly shareholding pattern of Biogen Pharmachem Industries Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Biogen Pharmachem Industries Ltd. on Sharpely?
Share price data for Biogen Pharmachem Industries Ltd. is updated as of 25 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.